From: The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee
APOE ε2-positive | APOE ε2-negative | p | |
---|---|---|---|
n = 13 | n = 107/103 a | ||
First trial period | |||
week 3 | 4.49 (0.71) | 5.05 (0.90) | |
week 7 | 4.52 (0.71) | 5.34 (0.93) | |
diff week 3–7 | 0.03 (0.57) | 0.29 (0.57) | 0.09 b |
p (diff 3–7) | 0.70 | <0.0001 c | |
Second trial period | |||
week 10 | 4.34 (0.64) | 4.95 (0.89) | |
week 14 | 4.54 (0.84) | 5.09 (0.85) | |
diff week 10–14 | 0.20 (0.47) | 0.14 (0.59) | 0.37 b |
p (diff 10–14) | 0.15 | 0.009 c |